Although there were no differences in the overall percentage of all monocytes in the blood of patients and controls (data not shown), more detailed analysis of monocyte subsets revealed fewer classical monocytes (CD14++CD16neg), but significantly more intermediate monocytes (CD14++/+CD16+) in patients with breast cancer. The gene discussed is CD14; the disease is breast carcinoma.